Pfizer Inc
NYSE: PFE
$25.95
Real Time Data Delayed 15 Min.
PFE Articles
Pfizer reported mixed first-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Apple, Facebook, Pfizer and some of the other top companies reporting their latest results in the coming week.
Published:
Last Updated:
The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of these selected pharmaceutical stocks.
Published:
Last Updated:
Apple, DuPont, Goldman Sachs, and Pfizer led the DJIA to a lower close on Tuesday.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
With the major markets retreating from all-time highs, it began to look like the Trump rally was spent. Judging by the most shorted stocks traded on the New York Stock Exchange, overall short sellers...
Published:
Last Updated:
24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen a reaction from the health care vote in Congress, or lack thereof.
Published:
Last Updated:
Goldman Sachs, DuPont, Boeing, and Pfizer weighed on the Dow Jones Industrial Average Friday.
Published:
Last Updated:
DuPont, Chevron, Merck, and Pfizer sink the DJIA on Thursday.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The bull market is now eight years old, and markets still keep on hitting new highs. How have the short sellers been reacting to this pricey market?
Published:
Last Updated:
Chevron, Verizon, Pfizer, and Merck combined to weigh on the DJIA Tuesday.
Published:
Last Updated:
Merck and Pfizer each saw their shares sink early on Monday after the firms gave an update on their type 2 diabetes treatment.
Published:
Last Updated: